CD4 and pancreatic neoplasm: To determine whether the MDSC and Treg cell interactions are present also in the human pancreatic cancer, we have studied the expression of different immune markers (CD4, CD8, CD15, CD11b, Foxp3) in a cohort of PDAC patients (Figure 6).